In vivo protection by broadly neutralizing HIV antibodies

Research output: Contribution to journalEditorialAcademicpeer-review

38 Citations (Scopus)

Abstract

Passive immunization studies, including a recent one by Pegu et al., have repeatedly shown that HIV-specific broadly neutralizing antibodies (bnAbs) protect rhesus macaques from HIV acquisition. In vitro neutralization potency and in vivo protection correlate very strongly, supporting the quest for an HIV vaccine that induces potent bnAbs
Original languageEnglish
Pages (from-to)550-551
JournalTrends in Microbiology
Volume22
Issue number10
DOIs
Publication statusPublished - 2014

Cite this